Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Abroad (travel likely)RecruitingPHASE1

Conditions

Diabetes · Type1diabetes · T1D

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hygea Medical Clinic, Montreal, Quebec, Canada
Contact: Study coordinator (Louise Ullyatt) · louise@cmhygea.com

Study leads

Michael Tsoukas, M.D.
Principal Investigator
Clinique Medicale Hygea

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Prostate Cancer · Metabolic Syndrome · Obesity

Abroad (travel likely)RecruitingEARLY_PHASE1

London, Canada

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

Diabetes · Diabetic Retinopathy · Type 2 Diabetes Mellitus (T2DM)

Abroad (travel likely)Recruiting

Lanzhou, China · Shanghai, China

Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

Diabetes · Diabetes Mellitus

Abroad (travel likely)Recruiting

Lexington, United States

Health Behavior Intervention for Adults With Type 1 Diabetes

Type1diabetes

Abroad (travel likely)Recruiting

Atlanta, United States